0001179110-18-000165.txt : 20180102
0001179110-18-000165.hdr.sgml : 20180102
20180102201132
ACCESSION NUMBER: 0001179110-18-000165
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171229
FILED AS OF DATE: 20180102
DATE AS OF CHANGE: 20180102
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Misfeldt Dayton
CENTRAL INDEX KEY: 0001461466
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51531
FILM NUMBER: 18503131
MAIL ADDRESS:
STREET 1: C/O BAY CITY CAPITAL LLC
STREET 2: 750 BATTERY STREET, SUITE 400
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SUNESIS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001061027
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943295878
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 395 OYSTER POINT BOULEVARD
STREET 2: SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-266-3500
MAIL ADDRESS:
STREET 1: 395 OYSTER POINT BOULEVARD
STREET 2: SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: MOSAIC PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19980709
4
1
edgar.xml
FORM 4 -
X0306
4
2017-12-29
0
0001061027
SUNESIS PHARMACEUTICALS INC
SNSS
0001461466
Misfeldt Dayton
C/O SUNESIS PHARMACEUTICALS, INC.
395 OYSTER POINT BLVD., SUITE 400
SOUTH SAN FRANCISCO
CA
94080
1
1
0
0
Interim CEO
Stock Option (Right to Buy)
3.69
2017-12-29
4
A
0
200000
0
A
2027-12-29
Common Stock
200000
200000
D
The option vests monthly over six (6) months in equal installments subject to optionee's continued service to the Company.
/s/ Dayton Misfeldt
2018-01-02